Junyu Liu
600 Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Programmed oral delivery of peptide therapeutics for multiorgan targeting in metabolic disorders of hyperglycemia and hyperuricemia.
Journal: Science advances
Published: June 10, 2026
Low-intensity pulsed ultrasound combined with microbubbles enhances amphotericin B delivery across the blood-brain barrier for improved therapy of cryptococcal meningitis.
Journal: Drug delivery
Published: June 04, 2026
Enabling Clinical Translation of Oral Probiotics Through Formulation Engineering and Scalable Manufacturing.
Journal: Biotechnology journal
Published: March 09, 2026
De Novo Development of Bioresponsive Nanoparticles With Antimicrobial Activity to Treat Bacterial Infections.
Journal: Advanced healthcare materials
Published: December 02, 2025
Nano/micro-scale targeted RNA delivery systems for cancer therapy.
Journal: International journal of pharmaceutics
Published: September 22, 2025
Comparison of the Efficacy and Safety of Different Antifungal Regimen Combinations in Non-HIV and Non-transplant Cryptococcal Meningitis Patients with High Cryptococcal Count.
Journal: Mycopathologia
Published: August 08, 2025
YOLO-Citrus: a lightweight and efficient model for citrus leaf disease detection in complex agricultural environments.
Journal: Frontiers in plant science
Published: July 17, 2025
Metabolomics-based analysis of the correlation between lipid metabolites and thyroid carcinoma.
Journal: BMC biotechnology
Published: July 07, 2025
Surface decoration of bacteria generates robust living therapeutics for improved ulcerative colitis therapy.
Journal: Communications biology
Published: June 11, 2025
Clinical features and mortality risk factors in non-HIV elderly patients with cryptococcal meningitis: A retrospective cohort study from 2013 to 2022.
Journal: PLoS neglected tropical diseases
Published: May 17, 2025
Comparing the efficacy of efgartigimod and intravenous immunoglobulin on AQP4-IgG-positive neuromyelitis optica spectrum disorder during acute attacks.
Journal: British journal of clinical pharmacology
Published: March 22, 2025
Last Updated: 09/26/2026